Table 2. Inpatient and outpatient management related clinical data.
* Median
ICU: intensive care unit; BiPAP: Bilevel Positive Airway Pressure; HFOV: High-frequency oscillatory ventilation.
| Control No.19 | Case No.19 | P-value | |
| Admission related clinical data | |||
| ICU admission (%) | 10 (52.63) | 14/13 (68.42) | 0.31 |
| Disease severity (%) | |||
| Moderate | 3 (15.79) | 0 (0.00) | 0.10 |
| Severe | 9 (47.37) | 7 (36.84) | 0.99 |
| Critical | 7 (36.84) | 12 (63.16) | 0.28 |
| Received medications | |||
| Interferon (%) | 5 (26.32) | 5 (26.32) | 0.99 |
| Lopinavir/ritonavir (%) | 3 (15.79) | 4 (21.05) | 0.68 |
| Ribavirin (%) | 1 (5.26) | 1 (5.26) | 0.99 |
| Convalescent Plasma (%) | 0 (0.00) | 3 (15.79) | 0.07 |
| Systemic steroid (%) | 13 (68.42) | 14 (73.68) | 0.72 |
| Tocilizumab (%) | 6 (31.58) | 11 (57.89) | 0.10 |
| Ventilatory support | |||
| Nasal cannula /Face mask (%) | 13 (68.42) | 17 (89.47) | 0.11 |
| High flow nasal cannula (%) | 6 (31.58) | 8 (42.11) | 0.50 |
| BiPAP (%) | 3 (15.79) | 4 (21.05) | 0.67 |
| Mechanical ventilator (%) | 1 (5.26) | 8 (42.11) | 0.008 |
| HFOV (%) | 1 (5.26) | 2 (10.53) | 0.55 |
| Discharge related clinical data | |||
| Systemic steroid after discharge (%) | 9 (47.37) | 15 (78.95) | 0.043 |
| Oxygen at discharge (%) | 4 (21.05) | 7 (36.84) | 0.28 |
| Readmission within 4 weeks of discharge (%) | 2 (11.11) | 5 (26.32) | 0.23 |
| Weeks on systemic steroid (SD) | 4.00 (4.77) | 9.11 (8.43) | 0.03 |
| Weeks on home oxygen* (IQ) | 0.00 (0.00-4.00) | 0.00 (0.00-16.00) | 0.19 |